Lu Xu

Ms. Lu Xu

Shenyang Pharmaceutical University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
WZWei Zhang
Wei Zhang
MYMiaorong Yu
Miaorong Yu
ZXZiyue Xi
Ziyue Xi
DNDi Nie
Di Nie
ZDZhuo Dai
Zhuo Dai
LXLu Xu
Lu Xu

1 February 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
ZXZiyue Xi
Ziyue Xi
EAEjaj Ahmad
Ejaj Ahmad
WZWei Zhang
Wei Zhang
JLJingyi Li
Jingyi Li
AWAohua Wang
Aohua Wang
YGYong Gan
Yong Gan

23 December 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
WZWei Zhang
Wei Zhang
NZNan Zheng
Nan Zheng
LCLu Chen
Lu Chen
LXLuyao Xie
Luyao Xie
MCMingshu Cui
Mingshu Cui
LXLu Xu
Lu Xu
The use of mesoporous silica nanoparticles (MSNs) in the field of oral drug delivery has recently attracted greater attention. However, there is still limited knowledge about how the shape of MSNs affects drug delivery capacity. In our study, we fabricated mesoporous silica nanorods (MSNRs) to study the shape effects of MSNs on oral delivery. MSNRs were characterized by transmission electron microscopy (TEM), nitrogen adsorption/desorption, Fourier transform infrared spectroscopy (FTIR), and small-angle X-ray diffraction (small-angle XRD). Indomethacin (IMC), a non-steroidal anti-inflammatory agent, was loaded into MSNRs as model drug, and the drug-loaded MSNRs resulted in an excellent dissolution-enhancing effect. The cytotoxicity and in vivo pharmacokinetic studies indicated that MSNRs can be applied as a safe and efficient candidate for the delivery of insoluble drugs. The use of MSNs with a rod-like shape, as a drug delivery carrier, will extend the pharmaceutical applications of silica materials.

17 August 2024 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
JLJiaping Liu
Jiaping Liu
ZXZiyue Xi
Ziyue Xi
CFChuanyong Fan
Chuanyong Fan
YMYihua Mei
Yihua Mei
JZJiale Zhao
Jiale Zhao
LXLu Xu
Lu Xu

10 February 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ZXZiyue Xi
Ziyue Xi
WZWei Zhang
Wei Zhang
YFYali Fei
Yali Fei
MCMingshu Cui
Mingshu Cui
LXLuyao Xie
Luyao Xie
LXLu Xu
Lu Xu
This work explored absorption efficacy via an in vivo imaging system and parallel artificial membrane penetration in indomethacin (IMC) solid dispersion (SD) systems. Two different polymer excipients—hydroxypropyl methylcellulose (HPMC) and Kollicoat IR as precipitation inhibitors (PIs)—combined with mesoporous silica nanoparticles (MSNs) as carriers were investigated. The IMC–SDs were prepared using the solvent evaporation method and characterized by solubility analysis, infrared (IR) spectroscopy, powder X-ray diffraction (PXRD), field emission scanning electron microscopy (FESEM), and differential scanning calorimetry (DSC). It was confirmed that IMC successfully changed into an amorphous state after loading into the designed carriers. The in vitro release and stability experiments were conducted to examine the in vitro dissolution rates of IMC–SDs combined with HPMC and Kollicoat IR as PIs which both improved approximately three-fold to that of the pure drug. Finally, in vivo studies and in vitro parallel artificial membrane penetration (PAMPA) experiments ensured the greater ability of enhancing the dissolution rates of pure IMC in the gastrointestinal tract by oral delivery. In brief, this study highlights the prominent role of HPMC and Kollicoat IR as PIs in MSN SD systems in improving the bioavailability and gastrointestinal oral absorption efficiency of indomethacin.

16 March 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
ZXZiyue Xi
Ziyue Xi
YFYali Fei
Yali Fei
YWYuxin Wang
Yuxin Wang
QLQing Lin
Qing Lin
QKQidong Ke
Qidong Ke
LXLu Xu
Lu Xu